This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (99)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Patient-Physician Communication  • Psychiatry  • Depression  • Randomized Controlled Trial  • Drug Therapy, Other  • Alert me on articles by topic

A Randomized Controlled Trial

Richard L. Kravitz, MD, MSPH; Ronald M. Epstein, MD; Mitchell D. Feldman, MD, MPhil; Carol E. Franz, PhD; Rahman Azari, PhD; Michael S. Wilkes, MD, PhD; Ladson Hinton, MD; Peter Franks, MD

JAMA. 2005;293:1995-2002.

Context  Direct-to-consumer (DTC) advertising of prescription drugs in the United States is both ubiquitous and controversial. Critics charge that it leads to overprescribing, while proponents counter that it helps avert underuse of effective treatments, especially for conditions that are poorly recognized or stigmatized.

Objective  To ascertain the effects of patients’ DTC-related requests on physicians’ initial treatment decisions in patients with depressive symptoms.

Design  Randomized trial using standardized patients (SPs). Six SP roles were created by crossing 2 conditions (major depression or adjustment disorder with depressed mood) with 3 request types (brand-specific, general, or none).

Setting  Offices of primary care physicians in Sacramento, Calif; San Francisco, Calif; and Rochester, NY, between May 2003 and May 2004.

Participants  One hundred fifty-two family physicians and general internists recruited from solo and group practices and health maintenance organizations; cooperation rates ranged from 53% to 61%.

Interventions  The SPs were randomly assigned to make 298 unannounced visits, with assignments constrained so physicians saw 1 SP with major depression and 1 with adjustment disorder. The SPs made a brand-specific drug request, a general drug request, or no request (control condition) in approximately one third of visits.

Main Outcome Measures  Data on prescribing, mental health referral, and primary care follow-up obtained from SP written reports, visit audiorecordings, chart review, and analysis of written prescriptions and drug samples. The effects of request type on prescribing were evaluated using contingency tables and confirmed in generalized linear mixed models that accounted for clustering and adjusted for site, physician, and visit characteristics.

Results  Standardized patient role fidelity was excellent, and the suspicion rate that physicians had seen an SP was 13%. In major depression, rates of antidepressant prescribing were 53%, 76%, and 31% for SPs making brand-specific, general, and no requests, respectively (P<.001). In adjustment disorder, antidepressant prescribing rates were 55%, 39%, and 10%, respectively (P<.001). The results were confirmed in multivariate models. Minimally acceptable initial care (any combination of an antidepressant, mental health referral, or follow-up within 2 weeks) was offered to 98% of SPs in the major depression role making a general request, 90% of those making a brand-specific request, and 56% of those making no request (P<.001).

Conclusions  Patients’ requests have a profound effect on physician prescribing in major depression and adjustment disorder. Direct-to-consumer advertising may have competing effects on quality, potentially both averting underuse and promoting overuse.

Author Affiliations: Center for Health Services Research in Primary Care (Drs Kravitz, Franz, Azari, Wilkes, Hinton, and Franks) and Departments of Internal Medicine (Drs Kravitz and Wilkes), Statistics (Dr Azari), Psychiatry (Dr Hinton), and Family and Community Medicine (Dr Franks), University of California, Davis, Sacramento; Departments of Family Medicine and Psychiatry and Center to Improve Communication in Health Care, University of Rochester School of Medicine and Dentistry, Rochester, NY (Dr Epstein); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (Dr Feldman).

RELATED LETTERS

Direct-to-Consumer Advertising and Physician Prescribing
Franklin G. Miller and David Wendler
JAMA. 2005;294(6):678.
EXTRACT | FULL TEXT  

Direct-to-Consumer Advertising and Physician Prescribing—Reply
Richard L. Kravitz, Peter Franks, Ronald M. Epstein, Mitchell D. Feldman, and Carol E. Franz
JAMA. 2005;294(6):678-679.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
Matthew F. Hollon
JAMA. 2005;293(16):2030-2033.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Too Many Referrals of Low-Risk Women for BRCA1/2 Genetic Services by Family Physicians
White et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2980-2986.
ABSTRACT | FULL TEXT  

National Trends in Psychotherapy by Office-Based Psychiatrists
Mojtabai and Olfson
Arch Gen Psychiatry 2008;65:962-970.
ABSTRACT | FULL TEXT  

Physicians' Shared Decision-Making Behaviors in Depression Care
Young et al.
Arch Intern Med 2008;168:1404-1408.
ABSTRACT | FULL TEXT  

Aiding Medical Decision Making: A Communication Perspective
Street
Med Decis Making 2007;27:550-553.
 

Understanding Mental Health Treatment in Persons Without Mental Diagnoses: Results From the National Comorbidity Survey Replication
Druss et al.
Arch Gen Psychiatry 2007;64:1196-1203.
ABSTRACT | FULL TEXT  

Let's Not Talk About It: Suicide Inquiry in Primary Care
Feldman et al.
Ann Fam Med 2007;5:412-418.
ABSTRACT | FULL TEXT  

A Decade of Direct-to-Consumer Advertising of Prescription Drugs
Donohue et al.
NEJM 2007;357:673-681.
ABSTRACT | FULL TEXT  

Physician Self-disclosure in Primary Care Visits: Enough About You, What About Me?
McDaniel et al.
Arch Intern Med 2007;167:1321-1326.
ABSTRACT | FULL TEXT  

Behind Closed Doors: Management of Patient Expectations in Primary Care Practices
Keitz et al.
Arch Intern Med 2007;167:445-452.
ABSTRACT | FULL TEXT  

Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising
Jagsi
JCO 2007;25:902-905.
FULL TEXT  

Time to Ban Direct-to-Consumer Prescription Drug Marketing
Stange
Ann Fam Med 2007;5:101-104.
FULL TEXT  

Ratings of Physician Communication by Real and Standardized Patients
Fiscella et al.
Ann Fam Med 2007;5:151-158.
ABSTRACT | FULL TEXT  

Assessment in Medical Education
Epstein
NEJM 2007;356:387-396.
FULL TEXT  

Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence
Raymond et al.
Psychiatr. Serv. 2007;58:79-84.
ABSTRACT | FULL TEXT  

In This Issue: Doctor-Patient and Drug Company-Patient Communication
Stange
Ann Fam Med 2007;5:2-4.
FULL TEXT  

Exploring and Validating Patient Concerns: Relation to Prescribing for Depression
Epstein et al.
Ann Fam Med 2007;5:21-28.
ABSTRACT | FULL TEXT  

Assessment of Clinical Skills Using Simulator Technologies
Srinivasan et al.
Acad. Psychiatry 2006;30:505-515.
ABSTRACT | FULL TEXT  

Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong et al.
Arch Intern Med 2006;166:2260-2265.
ABSTRACT | FULL TEXT  

The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and {omega}3 Fatty Acid Prescribing Behaviors
Oh et al.
J Am Board Fam Med 2006;19:459-467.
ABSTRACT | FULL TEXT  

Changing Profiles of Service Sectors Used for Mental Health Care in the United States
Wang et al.
Am. J. Psychiatry 2006;163:1187-1198.
ABSTRACT | FULL TEXT  

A Framework to Improve the Quality of Treatment for Depression in Primary Care
Croghan et al.
Psychiatr. Serv. 2006;57:623-630.
ABSTRACT | FULL TEXT  

Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.
Huskamp
Health Aff (Millwood) 2006;25:635-646.
ABSTRACT | FULL TEXT  

"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising
Grow et al.
Journal of Communication Inquiry 2006;30:163-188.
ABSTRACT  

Reconsidering medication appropriateness for patients late in life.
Holmes et al.
Arch Intern Med 2006;166:605-609.
FULL TEXT  

Physicians' responses to patients' medically unexplained symptoms.
Epstein et al.
Psychosom. Med. 2006;68:269-276.
ABSTRACT | FULL TEXT  

A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Lembo
JAMA 2006;295:925-933.
FULL TEXT  

Direct-to-Consumer Advertising in Oncology.
Abel et al.
The Oncologist 2006;11:217-226.
ABSTRACT | FULL TEXT  

Quality of Preventive Care for Diabetes: Effects of Visit Frequency and Competing Demands
Fenton et al.
Ann Fam Med 2006;4:32-39.
ABSTRACT | FULL TEXT  

How Hospitals Confront New Technology
Coye and Kell
Health Aff (Millwood) 2006;25:163-173.
ABSTRACT | FULL TEXT  

Medicine by media: Did a critical television documentary affect the prescribing of cyproterone- estradiol (Diane-35)?
Mintzes et al.
CMAJ 2005;173:1313-1315.
FULL TEXT  

Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing
Spence et al.
Med Care Res Rev 2005;62:544-559.
ABSTRACT  

Patient-Centered Communication and Diagnostic Testing
Epstein et al.
Ann Fam Med 2005;3:415-421.
ABSTRACT | FULL TEXT  

Direct-to-Consumer Advertising and Physician Prescribing
Miller and Wendler
JAMA 2005;294:678-678.
FULL TEXT  

PEDIATRICS & ADOLESCENT MEDICINE
Arch. Dis. Child. 2005;90:873-874.
FULL TEXT  

Direct-to-Consumer Advertising of Antidepressants and Prescribing Behavior
JWatch Psychiatry 2005;2005:2-2.
FULL TEXT  

Influence of Direct-to-Consumer Advertising on Antidepressant Prescriptions
JWatch General 2005;2005:1-1.
FULL TEXT  

Consumer advertising influences doctors' prescribing, study finds
Gottlieb
BMJ 2005;330:983-983.
FULL TEXT  

Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
Hollon
JAMA 2005;293:2030-2033.
FULL TEXT